NEXGEL Inc. (NXGL)
3.44
-0.09 (-2.55%)
At close: Jan 14, 2025, 3:59 PM
3.45
0.26%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 2.78 |
| Market Cap | 23.37M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.59 |
| PE Ratio (ttm) | -5.83 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.6 |
| Volume | 28,582 |
| Avg. Volume (20D) | 128,450 |
| Open | 3.52 |
| Previous Close | 3.53 |
| Day's Range | 3.36 - 3.53 |
| 52-Week Range | 1.84 - 5.10 |
| Beta | undefined |
About NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania....
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Dec 22, 2021
Employees 19
Stock Exchange NASDAQ
Ticker Symbol NXGL
Website https://nexgel.com
Next Earnings Release
NEXGEL Inc. is scheduled to release its earnings on Mar 27, 2025,
during market hours.
Analysts project revenue of $3.19M, reflecting a 194.82% YoY growth and earnings per share of -0.1, making a -50.00% decrease YoY.
Analysts project revenue of $3.19M, reflecting a 194.82% YoY growth and earnings per share of -0.1, making a -50.00% decrease YoY.
3 months ago ·
Source
+18.75%
NEXTGEL shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago ·
Source
-5.61%
NexGel shares are trading lower. The company reported Q2 financial results.
